Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy

被引：0
|
作者：
Pace, L. [1 ]
Klain, M. [1 ]
Soricelli, A. [2 ]
Albanese, C. [1 ]
Salvatore, B. [1 ]
Storto, G. [3 ]
Salvatore, M. [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Univ Parthenope, Naples, Italy
[3] CNR, IBB, I-80125 Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [1] Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment
    Leonardo Pace
    Michele Klain
    Carmine Albanese
    Barbara Salvatore
    Giovanni Storto
    Andrea Soricelli
    Marco Salvatore
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 179 - 183
  • [2] Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment
    Pace, L
    Klain, M
    Albanese, C
    Salvatore, B
    Storto, G
    Soricelli, A
    Salvatore, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (02) : 179 - 183
  • [3] Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
    Klain, Michele
    Pace, Leonardo
    Zampella, Emilia
    Mannarino, Teresa
    Limone, Simona
    Mazziotti, Emanuela
    De Simini, Giovanni
    Cuocolo, Alberto
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [4] The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial 131I therapy
    van Dijk, D.
    Plukker, J. T. M.
    van der Horst-Schrivers, A. N. A.
    Jansen, L.
    Brouwers, A. H.
    Muller-Kobold, A.
    Sluiter, W. J.
    Links, T. P.
    CLINICAL ENDOCRINOLOGY, 2011, 74 (01) : 104 - 110
  • [5] Second primary cancer after 131-iodine therapy in differentiated thyroid cancer (DTC) patients in the Veneto (Italy).
    Casara, D
    Saladini, G
    Rubello, D
    Mazzarotto, R
    Sotti, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 987 - 987
  • [6] Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin
    de Keizer, B
    Koppeschaar, HPF
    Zelissen, PMJ
    Lips, GJM
    van Rijk, PP
    van Dijk, A
    de Kerk, JMH
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (02) : 198 - 202
  • [7] Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin
    Bart de Keizer
    Hans P. F. Koppeschaar
    Pierre M. J. Zelissen
    Cees J. M. Lips
    Peter P. van Rijk
    Aalt van Dijk
    John M. H. de Klerk
    European Journal of Nuclear Medicine, 2001, 28 : 198 - 202
  • [8] Concentration of Thyroglobulin and Thyroglobulin-Specific Autoantibodies in Patients With Differentiated Thyroid Cancer After Treatment With Radioactive Iodine 131
    Vrndic, Olgica B.
    Savin, Svetlana B.
    Mijatovic, Ljiljana C.
    Djukic, Aleksandar A.
    Jeftic, Ilija D.
    Simonovic, Snezana T. Zivancevic
    LABMEDICINE, 2011, 42 (01): : 27 - 31
  • [9] Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases
    Pedro W. Rosario
    Gabriela F. Mourão
    Thassio L. Siman
    Maria R. Calsolari
    Endocrine, 2015, 49 : 279 - 282
  • [10] Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases
    Rosario, Pedro W.
    Mourao, Gabriela F.
    Siman, Thassio L.
    Calsolari, Maria R.
    ENDOCRINE, 2015, 49 (01) : 279 - 282
12345